Institution · Cancer Research Center
Most cited papers from Cancer Research Center
What are the most cited papers from Cancer Research Center?
The most cited paper from Cancer Research Center is "Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer" (Julie Renee Brahmer et al., 2012), with 8,100 citations. Next come "Evaluating the public health impact of health promotion interventions: the RE-AIM framework." (7,552) and "Prevention of HIV-1 Infection with Early Antiretroviral Therapy" (7,006).
Showing 50 of 60 papers. Every paper with more than 1,783 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer Julie Renee Brahmer et al. · New England Journal of Medicine | 14 Jun 2012 | 8,100 |
| 2 | Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Russell E. Glasgow, THOMAS M. VOGT, Shawn M. Boles · American Journal of Public Health | Sep 1999 | 7,552 |
| 3 | Prevention of HIV-1 Infection with Early Antiretroviral Therapy Myron S. Cohen et al. · New England Journal of Medicine | 18 Jul 2011 | 7,006 |
| 4 | The Immune Landscape of Cancer Vésteinn Thórsson et al. · Immunity | Apr 2018 | 6,328 |
| 5 | New Perspectives in Cell Adhesion: RGD and Integrins Erkki I. Ruoslahti, Michael D. Pierschbacher · Science | 23 Oct 1987 | 4,905 |
| 6 | Predicting Obesity in Young Adulthood from Childhood and Parental Obesity Robert C. Whitaker, Jeffrey A. Wright, MARGARET SULLIVAN PEPE et al. · New England Journal of Medicine | 25 Sep 1997 | 4,434 |
| 7 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Jianfang Liu et al. · Cell | Apr 2018 | 4,058 |
| 8 | Cancer immunotherapy comes of age Ira Mellman, George Coukos, Glenn Dranoff · Nature | 20 Dec 2011 | 3,936 |
| 9 | Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey et al. · Nature | 23 Feb 2016 | 3,805 |
| 10 | Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule Michael D. Pierschbacher, Erkki I. Ruoslahti · Nature | May 1984 | 3,684 |
| 11 | Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease Gilbert S. Omenn, Gary E. Goodman, Mark D. Thornquist et al. · New England Journal of Medicine | 2 May 1996 | 3,667 |
| 12 | Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer et al. · Journal of Clinical Oncology | 4 Oct 2011 | 3,651 |
| 13 | Chronic Health Conditions in Adult Survivors of Childhood Cancer Kevin Charles Oeffinger, Ann C. Mertens, Charles A. Sklar et al. · New England Journal of Medicine | 11 Oct 2006 | 3,647 |
| 14 | Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia Brian J. Druker et al. · New England Journal of Medicine | 6 Dec 2006 | 3,508 |
| 15 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hartmut Döhner, Elihu H. Estey, Sergio Amadori et al. · Blood | 30 Oct 2009 | 3,422 |
| 16 | Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis Raoul Herbrecht et al. · New England Journal of Medicine | 8 Aug 2002 | 3,326 |
| 17 | Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Anne P. Monks, Dominic A. Scudiero, Philip Skehan et al. · JNCI Journal of the National Cancer Institute | 5 Jun 1991 | 3,295 |
| 18 | Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping Johanna M. Rommens, Michael C. Iannuzzi, Bat-Sheva Kerem et al. · Science | 8 Sep 1989 | 3,269 |
| 19 | RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS Erkki I. Ruoslahti · Annual Review of Cell and Developmental Biology | Nov 1996 | 3,202 |
| 20 | Revised International Prognostic Scoring System for Myelodysplastic Syndromes Peter L. Greenberg et al. · Blood | 28 Jun 2012 | 3,195 |
| 21 | Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Rie Watanabe‐Fukunaga, Camilynn I. Brannan, Neal G. Copeland et al. · Nature | Mar 1992 | 2,919 |
| 22 | Detection and localization of surgically resectable cancers with a multi-analyte blood test Joshua David Cohen et al. · Science | 18 Jan 2018 | 2,879 |
| 23 | Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children Alexander Edward Dela Cruz Drilon et al. · New England Journal of Medicine | 21 Feb 2018 | 2,827 |
| 24 | Whole genomes redefine the mutational landscape of pancreatic cancer Australian Pancreatic Cancer Genome Initiative et al. · Nature | 24 Feb 2015 | 2,727 |
| 25 | Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Sunil R. Hingorani, Lifu Wang, Asha S. Multani et al. · Cancer Cell | May 2005 | 2,703 |
| 26 | Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer Herbert Barton Grossman, Ronald B. Natale, Catherine M. Tangen et al. · New England Journal of Medicine | 27 Aug 2003 | 2,691 |
| 27 | Pancreatic cancer Audrey Vincent, Joseph M. Herman, Richard Schulick et al. · The Lancet | 29 May 2011 | 2,630 |
| 28 | Distant metastasis occurs late during the genetic evolution of pancreatic cancer Shinichi Yachida, Siân Jones, Ivana Božić et al. · Nature | Oct 2010 | 2,563 |
| 29 | SIFT web server: predicting effects of amino acid substitutions on proteins Ngak-Leng Sim, P. Naresh Kumar, Jing Hu et al. · Nucleic Acids Research | 9 Jun 2012 | 2,531 |
| 30 | Elucidation of a Universal Size-Control Mechanism in Drosophila and Mammals Jixin Dong, Georg Feldmann, Jianbin Huang et al. · Cell | Sep 2007 | 2,467 |
| 31 | Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter Ian Murchie Thompson, Donna K. Pauler, Phyllis J. Goodman et al. · New England Journal of Medicine | 26 May 2004 | 2,448 |
| 32 | Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis Nagendra Kumar Singh, Ashish Gurav, Sathish Sivaprakasam et al. · Immunity | 2014 | 2,363 |
| 33 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas Masao Tanaka, Carlos Fernández-del Castillo, Volkan N. Adsay et al. · Pancreatology | May 2012 | 2,359 |
| 34 | Genome-wide association study identifies novel breast cancer susceptibility loci Douglas F. Easton et al. · Nature | 27 May 2007 | 2,342 |
| 35 | Body-Mass Index and Mortality among 1.46 Million White Adults Amy Berrington de González et al. · New England Journal of Medicine | Dec 2010 | 2,341 |
| 36 | Olaparib for Metastatic Castration-Resistant Prostate Cancer Johann Sebastian De Bono, Joaquı́n Mateo, Karim S. Fizazi et al. · New England Journal of Medicine | 28 Apr 2020 | 2,322 |
| 37 | A draft map of the human proteome Min‐Sik Kim et al. · Nature | 27 May 2014 | 2,319 |
| 38 | Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Gina M. DeNicola, Florian A. Karreth, Timothy J. Humpton et al. · Nature | Jul 2011 | 2,302 |
| 39 | Mass spectrometry‐based metabolomics Katja Dettmer, Pavel A. Aronov, Bruce D. Hammock · Mass Spectrometry Reviews | 18 Aug 2006 | 2,273 |
| 40 | Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Richard Maury Stone et al. · New England Journal of Medicine | 23 Jun 2017 | 2,258 |
| 41 | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product Donald Paul Bottaro, Jeffrey S. Rubin, Donna L. Faletto et al. · Science | 15 Feb 1991 | 2,257 |
| 42 | Pancreatic cancer Terumi Kamisawa, Laura DeLong Wood, Takao Itoi et al. · The Lancet | 30 Jan 2016 | 2,242 |
| 43 | Organoid Models of Human and Mouse Ductal Pancreatic Cancer Sylvia F. Boj et al. · Cell | 31 Dec 2014 | 2,219 |
| 44 | Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials Laura Fulper Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine | 30 Dec 1999 | 2,203 |
| 45 | Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Toshiyuki Miyashita, Stanisław Krajewski, Maryla Krajewska et al. · PubMed | Jun 1994 | 2,164 |
| 46 | EMT and Dissemination Precede Pancreatic Tumor Formation Andrew D. Rhim, Emily T. Mirek, Nicole M. Aiello et al. · Cell | 2012 | 2,158 |
| 47 | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes Australian Pancreatic Cancer Genome Initiative et al. · Nature | 24 Oct 2012 | 2,133 |
| 48 | Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma Andrew D. Rhim, Paul E. Oberstein, Dafydd Thomas et al. · Cancer Cell | 22 May 2014 | 2,087 |
| 49 | Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model Wadih Arap, Renata Pasqualini, Erkki I. Ruoslahti · Science | 16 Jan 1998 | 2,065 |
| 50 | Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity Ludovico Cantuti‐Castelvetri et al. · Science | 20 Oct 2020 | 2,038 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.